James T. Dalton
101Patents
22h-index
64Co-inventors
93Inventor score
Filing activity: Nov 25, 1997 → Mar 14, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6569896B2 | Selective androgen receptor modulators and methods of use thereof | Physics | 112 | Expired |
| US6492554B2 | Selective androgen receptor modulators and methods of use thereof | Physics | 91 | Expired |
| US6838484B2 | Formulations comprising selective androgen receptor modulators | Physics | 84 | Expired |
| US6995284B2 | Synthesis of selective androgen receptor modulators | Physics | 81 | Expired |
| US6071957A | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer | Chemistry; Metallurgy | 81 | Expired |
| US7022870B2 | N-bridged selective androgen receptor modulators and methods of use thereof | Chemistry; Metallurgy | 75 | Expired |
| US6019957A | Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging | Chemistry; Metallurgy | 73 | Expired |
| US7026500B2 | Halogenated selective androgen receptor modulators and methods of use thereof | Chemistry; Metallurgy | 71 | Expired |
| US6998500B2 | Selective androgen receptor modulators and methods of use thereof | Chemistry; Metallurgy | 69 | Expired |
| US6160011A | Non-steroidal agonist compounds and their use in male hormone therapy | Chemistry; Metallurgy | 61 | Expired |
| US6482861B2 | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer | Chemistry; Metallurgy | 56 | Expired |
| US7772433B2 | SARMS and method of use thereof | Human Necessities | 42 | Active |
| US7205437B2 | Selective androgen receptor modulators | Chemistry; Metallurgy | 35 | Expired |
| US8008348B2 | Treating muscle wasting with selective androgen receptor modulators | Human Necessities | 31 | Active |
| US7622503B2 | Selective androgen receptor modulators and methods of use thereof | Human Necessities | 29 | Expired |
| US7547728B2 | Treating muscle wasting with selective androgen receptor modulators | Emerging Cross-Sectional Technologies | 29 | Expired |
| US8080682B2 | Substituted acylanilides and methods of use thereof | Chemistry; Metallurgy | 28 | Active |
| US7214693B2 | Heterocyclic selective androgen receptor modulators and methods of use thereof | Chemistry; Metallurgy | 26 | Expired |
| US7041844B2 | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer | Chemistry; Metallurgy | 25 | Expired |
| US7344700B2 | Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy | Human Necessities | 25 | Expired |
| US7645898B2 | Selective androgen receptor modulators and method of use thereof | Chemistry; Metallurgy | 25 | Active |
| US7705182B2 | Multi-substituted selective androgen receptor modulators and methods of use thereof | Human Necessities | 23 | Active |
| US7759520B2 | Synthesis of selective androgen receptor modulators | Chemistry; Metallurgy | 21 | Expired |
| US7518013B2 | Selective androgen receptor modulators | Chemistry; Metallurgy | 21 | Expired |
| US8822513B2 | Compounds for treatment of cancer | Chemistry; Metallurgy | 20 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.